Lexapro and Wellbutrin are both widely prescribed antidepressants, but they work through entirely different brain pathways and come with distinct side effect profiles — which means the “better” choice depends almost entirely on your specific symptoms, medical history, and what you can tolerate. Lexapro (escitalopram) is a selective serotonin reuptake inhibitor, or SSRI, that boosts serotonin and carries FDA approval for both major depressive disorder and generalized anxiety disorder. Wellbutrin (bupropion) is a norepinephrine-dopamine reuptake inhibitor, or NDRI, approved for major depressive disorder, seasonal affective disorder, and smoking cessation. For someone dealing with depression alongside significant anxiety, a psychiatrist will often lean toward Lexapro.
For someone whose chief concerns include fatigue, low motivation, or who has experienced sexual side effects on other antidepressants, Wellbutrin frequently becomes the first conversation. A clinical trial published in PMC found no statistically significant difference in short-term recovery rates between escitalopram and bupropion, and a separate study of roughly 800 participants reached a similar conclusion — both medications proved comparably effective at improving depression symptoms. That said, comparable average outcomes do not mean they are interchangeable for a given person. Roughly 46 percent of users do not respond adequately to a single antidepressant alone, and when augmentation is needed, bupropion is the most widely chosen add-on agent paired with SSRIs across the United States and Canada. This article walks through the mechanistic differences, side effect tradeoffs, cost considerations, and the specific clinical scenarios where one medication tends to outperform the other — particularly for older adults and those managing cognitive health concerns.
Table of Contents
- How Do Lexapro and Wellbutrin Differ in the Way They Work on the Brain?
- Side Effects That Actually Drive Most Switching Decisions
- What the Research Says About Effectiveness in Depression
- Cost and Access — What You Will Actually Pay
- The Black Box Warning and Safety Considerations That Apply to Both
- When Prescribers Use Both Medications Together
- Thinking About Brain Health Beyond Depression Treatment
- Conclusion
- Frequently Asked Questions
How Do Lexapro and Wellbutrin Differ in the Way They Work on the Brain?
The core distinction is neurochemical. Lexapro selectively blocks the reuptake of serotonin, leaving more of it available in the synaptic cleft. Serotonin plays a broad regulatory role in mood, sleep, appetite, and anxiety. By contrast, Wellbutrin blocks the reuptake of both dopamine and norepinephrine — two neurotransmitters more closely tied to motivation, energy, concentration, and reward processing. Neither drug directly affects the other’s primary target, which is why their side effect profiles look so different and why they are sometimes prescribed together. this mechanistic split has practical consequences.
A person whose depression presents primarily as persistent worry, tension, and difficulty calming down is often better served by the serotonin-modulating effects of Lexapro, which has strong demonstrated anti-anxiety benefits. Someone whose depression looks more like profound fatigue, difficulty concentrating, loss of interest in activities, and low drive may find that Wellbutrin’s dopamine and norepinephrine activity addresses their symptoms more directly. For older adults or those concerned about cognitive health, this distinction matters — dopamine and norepinephrine are both involved in executive function and attention, areas that become increasingly relevant as people age or face early cognitive changes. It is worth noting that these are tendencies, not guarantees. The brain’s neurotransmitter systems interact in complex ways, and predicting exactly how a given individual will respond to either drug remains an imperfect science. The best approach is still an informed conversation with a prescriber who understands your full clinical picture.
Side Effects That Actually Drive Most Switching Decisions
In clinical practice, the reason people switch between these two medications usually comes down to tolerability rather than efficacy. The side effect profiles are starkly different. Up to 7 percent of Lexapro users in clinical trials reported reduced sex drive, and 9 to 14 percent reported ejaculation-related issues. Some researchers estimate that as many as 80 percent of SSRI-related side effects involve sexual dysfunction in some form. Wellbutrin, by contrast, has minimal to no reported incidence of decreased libido — it is one of the very few antidepressants that largely spares sexual function. Weight is another major divergence. Lexapro is associated with slight weight gain during long-term use, while Wellbutrin tends to be weight-neutral or is even associated with modest weight loss. For patients already managing metabolic concerns or taking other medications that promote weight gain, this difference can be decisive.
However, Wellbutrin is not without its own tolerability issues. Headaches affect up to 25 percent of patients on bupropion — a figure that often surprises people. Headaches are not commonly reported with Lexapro. The most important safety distinction involves seizure risk. Wellbutrin lowers the seizure threshold and is contraindicated in patients with a history of seizures or active eating disorders such as bulimia, where electrolyte imbalances can further increase that risk. If you or a family member has any seizure history, this is a hard disqualifying factor that your prescriber needs to know about. On the anxiety front, Wellbutrin can actually increase anxiety in some individuals, which is essentially the opposite of what Lexapro does. For someone whose depression is heavily intertwined with anxiety — a common pattern in older adults dealing with cognitive concerns or caregiver stress — starting Wellbutrin without addressing the anxiety component can make things worse before they get better.
What the Research Says About Effectiveness in Depression
Both medications have solid evidence behind them, though the data look somewhat different depending on the population studied and the timeframe examined. Lexapro has shown a roughly 90 percent response rate within four weeks in some studies, and about 80 percent of participants with comorbid depression and anxiety reported improvement. Wellbutrin’s response rate exceeds 50 percent after eight weeks, and in a meta-analysis of 27 clinical studies, 24 of those 27 reported a significant reduction in depression symptoms. These numbers are not directly comparable — different studies use different definitions of “response” and “improvement,” and the patient populations vary. What the head-to-head data do suggest is rough equivalence. The PMC-published clinical trial that directly compared escitalopram and bupropion found no statistically significant difference in short-term recovery rates.
The study of approximately 800 participants reached a similar conclusion. For the average patient with moderate depression, both drugs are reasonable first-line options. Where the picture gets more nuanced is in treatment-resistant cases. When a first antidepressant fails — which happens in nearly half of patients — bupropion is the single most common augmentation agent added to an existing ssri regimen in the U.S. and Canada. This means many people end up taking both drugs together, a combination strategy we will discuss further below.
Cost and Access — What You Will Actually Pay
Cost is a legitimate clinical consideration, especially for older adults on fixed incomes or anyone managing multiple prescriptions. Brand-name Lexapro runs roughly $440 to $566 per month without insurance. Brand-name Wellbutrin XL falls in the range of $150 to over $400 per month. Neither is cheap at retail price. The good news is that both medications are available as generics, and the price drops dramatically. Generic escitalopram costs roughly $15 to $120 per month at standard pharmacy prices, and can go as low as $7 to $9 with discount programs like GoodRx or SingleCare coupons.
Generic bupropion runs about $40 to $192 per month, and drops to as low as $6 to $9 with coupons — Cost Plus Drugs lists 30 extended-release bupropion tablets at $5.83. For most people with any form of insurance or access to a discount card, both medications are affordable. However, if you are comparing out-of-pocket costs without any assistance, generic escitalopram tends to be the less expensive option at the low end of the range. One practical note: Wellbutrin comes in three formulations — immediate release (dosed two to four times daily), sustained release (one to two times daily), and extended release or XL (once daily). The XL formulation is generally preferred for adherence and steady blood levels, but the different formulations can vary in price. Lexapro is simpler — it comes as tablets in 5 mg, 10 mg, and 20 mg strengths, plus an oral solution at 5 mg per 5 mL. Fewer options means fewer pricing complications.
The Black Box Warning and Safety Considerations That Apply to Both
Both Lexapro and Wellbutrin carry an FDA black box warning — the most serious type of drug safety alert — for increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults. This warning applies to essentially all antidepressants and does not mean these medications cause suicide. It means that during the early weeks of treatment, particularly in younger patients, close monitoring is essential. For older adults, this risk is statistically lower, but any new onset of agitation, restlessness, or worsening mood after starting either medication warrants an immediate call to the prescriber. Beyond the black box warning, there are drug-specific contraindications that matter. Wellbutrin should not be prescribed to anyone currently taking a monoamine oxidase inhibitor, or within 14 days of stopping one. The seizure risk mentioned earlier bears repeating: it is dose-dependent, meaning the risk increases at higher doses and with abrupt dose changes.
Alcohol withdrawal and benzodiazepine withdrawal also raise seizure risk in combination with bupropion. Lexapro carries a risk of serotonin syndrome when combined with other serotonergic drugs, including certain migraine medications (triptans), the pain medication tramadol, and St. John’s Wort. For anyone managing a complex medication regimen — which describes many older adults — a thorough medication reconciliation is not optional, it is critical. Neither medication should be stopped abruptly. Lexapro discontinuation can produce a well-documented withdrawal syndrome involving dizziness, irritability, brain zaps, and flu-like symptoms. Wellbutrin discontinuation is generally milder but should still be tapered under guidance.
When Prescribers Use Both Medications Together
Combination therapy with Lexapro and Wellbutrin is a well-established strategy for treatment-resistant depression, and it is more common than many patients realize. The rationale is pharmacologically elegant: Wellbutrin can counteract the sexual side effects and weight gain that Lexapro may cause, while Lexapro covers the anxiety symptoms that Wellbutrin does not address — and may actually worsen. Together, they hit three neurotransmitter systems (serotonin, dopamine, and norepinephrine) instead of one.
However, the combination is not risk-free. Concurrent use may increase seizure risk beyond what either drug carries alone. The decision to combine them should involve careful dose management and ongoing monitoring. For older adults and those with neurological concerns, this is a conversation that ideally involves a psychiatrist rather than a primary care provider alone, given the complexity of balancing efficacy against safety in a potentially vulnerable brain.
Thinking About Brain Health Beyond Depression Treatment
For readers of a brain health and dementia care site, the connection between depression treatment and long-term cognitive outcomes deserves attention. Untreated or undertreated depression is itself a risk factor for cognitive decline and dementia — the evidence on this has grown considerably. Choosing and maintaining an effective antidepressant is not just about feeling better today; it may be part of protecting cognitive function over the years ahead.
Wellbutrin’s dopaminergic activity has attracted some interest in research contexts related to attention and executive function in aging populations, though it is not approved for any cognitive indication. Lexapro’s anxiolytic properties can be valuable for the behavioral and psychological symptoms that sometimes accompany early cognitive changes. Neither medication is a cognitive enhancer, but adequately treating depression and anxiety removes a significant obstacle to clear thinking at any age. The best antidepressant for brain health is the one that effectively treats your depression with tolerable side effects — because that is the one you will actually take consistently.
Conclusion
Lexapro and Wellbutrin are both effective, well-studied antidepressants that happen to work through completely different mechanisms and carry very different side effect profiles. Lexapro tends to be the stronger choice when anxiety is a primary feature, while Wellbutrin often wins out for patients concerned about sexual dysfunction, weight gain, or low energy. Head-to-head data show comparable efficacy in the short term, and for the roughly 46 percent of patients who do not respond to a single agent, combining both medications is the most commonly used augmentation strategy in North America.
The right choice depends on your specific symptom profile, your medical history (particularly any seizure risk), your other medications, and what side effects you are willing to accept. Do not let cost be the deciding factor in a vacuum — both generics are affordable, especially with discount programs — but do raise cost concerns with your prescriber if they are relevant. Most importantly, if your current antidepressant is not working well enough or the side effects are undermining your quality of life, that is not a reason to stop treatment. It is a reason to have a frank conversation with your doctor about alternatives, adjustments, or combination strategies.
Frequently Asked Questions
Can I switch directly from Lexapro to Wellbutrin?
Switching antidepressants should always be done under medical supervision. In many cases, prescribers will cross-taper — gradually reducing Lexapro while slowly introducing Wellbutrin — rather than making an abrupt switch. This minimizes withdrawal symptoms from Lexapro and allows monitoring for any adverse reactions to bupropion.
Will Wellbutrin help with anxiety the way Lexapro does?
Generally, no. Wellbutrin is not FDA-approved for any anxiety disorder and can actually worsen anxiety in some individuals, particularly during the early weeks of treatment. If anxiety is a significant part of your clinical picture, Lexapro or another SSRI is usually the safer starting point.
Is one medication safer than the other for older adults?
Both are prescribed to older adults, but the considerations differ. Lexapro is generally well-tolerated in elderly populations, though SSRIs can increase fall risk due to effects on sodium levels and balance. Wellbutrin avoids some of those SSRI-specific concerns but carries the seizure risk, which may be relevant for older adults with neurological conditions. Neither is universally “safer” — it depends on the individual’s full medical profile.
How long does it take to know if either medication is working?
Most prescribers recommend giving an antidepressant at least four to eight weeks at an adequate dose before concluding it is ineffective. Some patients notice improvement within the first two weeks, but the full therapeutic effect often takes longer. Lexapro studies have shown response rates as high as 90 percent within four weeks, while Wellbutrin data typically cite response rates exceeding 50 percent after eight weeks.
Can I take Wellbutrin and Lexapro together?
Yes, this is a common combination in clinical practice, particularly for treatment-resistant depression or to counteract SSRI side effects like sexual dysfunction and weight gain. However, the combination may increase seizure risk, and it should only be initiated and monitored by a qualified prescriber.
Are the generic versions as effective as the brand names?
FDA-approved generics must demonstrate bioequivalence to the brand-name drug, meaning they deliver the same active ingredient at the same rate and extent. For the vast majority of patients, generic escitalopram and generic bupropion are clinically equivalent to Lexapro and Wellbutrin. The cost savings are substantial — generics can be found for under $10 per month with discount programs compared to several hundred dollars for brand-name versions.
